Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type.
Sahakian
B J
BJ
Coull
J J
JJ
Hodges
J R
JR
D000284:Administration, Oral; D003071:Cognition / Q000187:drug effects; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004146:Dioxanes / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D005625:Frontal Lobe / Q000187:drug effects / Q000503:physiopathology*; D006801:Humans; D019329:Idazoxan; D008297:Male; D010919:Placebos; D011942:Receptors, Adrenergic, alpha; D016896:Treatment Outcome; D014705:Verbal Behavior / Q000187:drug effects
D004146:Dioxanes; D010919:Placebos; D011942:Receptors, Adrenergic, alpha; D019329:Idazoxan